• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK USA, INC BKP CEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK USA, INC BKP CEMENT Back to Search Results
Model Number MSB_UNK_BKP_CEMENT
Device Problem Leak/Splash (1354)
Patient Problems Extravasation (1842); Bone Fracture(s) (1870); Unspecified Infection (1930); Pain (1994); Intervertebral Disc Compression or Protrusion (4524)
Event Date 09/06/2019
Event Type  Injury  
Manufacturer Narrative
Age: mean age of 76 years (range 69-87 years). Sex: 11 male and 43 female patients. Product code: ndn. Common device name: cement, bone, vertebroplast. Country: (b)(6). Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation. Therefore, we are unable to determine the definitive cause of the reported event. If information is provided in the future, a supplemental report will be issued.
 
Event Description
Citation: gaston camino willhuber, gonzalo kido, matias pereira duarte, martin estefan, mariana bendersky, julio bassani, matias petracchi, marcelo gruenberg, and carlos sola. Percutaneous cement discoplasty for the treatment of advanced degenerative disc conditions: a case series analysis. Retrospective analysis. Global spine journal 2020, vol. 10(6) 729-734. Doi: 10. 1177/2192568219873885. Event summary: it was reported from the literature article that fifty-four patients with advanced disc disease with/without degenerative scoliosis treated with pd with at least 1 year follow-up were studied to describe the results after a minimum 1-year follow-up in patients treated with percutaneous discoplasty (pd), a minimally invasive technique to treat low back pain in elderly patients with advanced degenerative disc disease. The procedure consists in improving stability by injecting bone cement in a severely degenerated pneumodisc. A prospective case-series analysis was conducted. Between december 2015 and september 2017 with inclusion criteria of patients older than 65 years, history of mechanical low back pain reluctant to a minimum of 6 months of conservative treatment, tomographic evidence of vacuum phenomenon and subchondral sclerosis at the affected level and variation in intervertebral disc alignment at the levels involved between standing and supine radiographs in both anteroposterior and lateral views (accordion phenomenon). Based on the diagnosis, 2 groups were created: the scoliotic group with 37 cases of degenerative scoliosis, and a nonscoliotic group with 15 cases of advanced degenerative disc disease without scoliosis plus 2 cases of degenerative spondylolisthesis.  fifty-four patients fulfilled the inclusion criteria: 11 males and 43 females with a mean age of 76 years (range 69-87 years). A total of 131 levels were treated, with an average of 2. 5 levels per patient (range of 1-5 levels). Pd was performed in 5 patients at the t12-l1 level; 16 patients at l1-l2; 29 patients at l2-l3; 26 patients at l3-l4; 32 patients at l4-l5, and 23 patients at l5-s1.  the average operating room time was 38 minutes (range 18-52 minutes). The mean follow-up was 16. 8 months + 3. 3 (range 12-21 months).  polymethylmethacrylate (pmma) (kyphon hv-r bone cement) was slowly injected through the cannula with special attention to detect any sign of cement leakage into the canal or the foraminal space. Reported events: there were no cases of clinical complications such as pneumonia, urinary infection, venous thrombosis, and so on. 1.  four cases required foraminal decompression due to radicular symptoms within 90 days (7. 4%), within these cases; 2 had cement leakage to the foramen, 1 case experienced a disc extrusion, and 1 case had lbp relief but persistent sciatic pain that required foraminal decompression. 2. One patient presented a deep infection. 3. One patient presented a vertebral fracture adjacent to the discoplasty that required a vertebroplasty.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameBKP CEMENT
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer Contact
tricha miles
1800 pyramid place
memphis, TN 38132
7635140379
MDR Report Key11869137
MDR Text Key252923344
Report Number1030489-2021-00682
Device Sequence Number1
Product Code NDN
Combination Product (y/n)N
Reporter Country CodeAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation
Type of Report Initial
Report Date 05/24/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/24/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator
Device Model NumberMSB_UNK_BKP_CEMENT
Device Catalogue NumberMSB_UNK_BKP_CEMENT
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional?
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received05/02/2021
Was Device Evaluated by Manufacturer? No Answer Provided
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage

Patient Treatment Data
Date Received: 05/24/2021 Patient Sequence Number: 1
-
-